Correspondence 0001829126-23-000012 from Rubicon Technologies, Inc. (RBTC, RBTCW) (CIK 0001862068)
Rubicon Technologies, Inc. (RBTC, RBTCW) (CIK 0001862068)
Date: Jan. 3, 2023 · CIK: 0001862068 · Accession: 0001829126-23-000012
AI Filing Summary & Sentiment
File numbers found in text: 333-267010
Referenced dates: December 28, 2022
Show Raw Text
CORRESP
1
filename1.htm
January
3, 2023
VIA
EDGAR
Kathleen
Krebs, Special Counsel
Priscilla
Dao, Staff Attorney
Securities
and Exchange Commission
Division
of Corporation Finance
Office
of Technology
100
F Street, NE
Washington,
D.C. 20549-3561
Re:
Rubicon
Technologies, Inc.
Registration
Statement on Form S-1/A
Filed
November 28, 2022
File
No. 333-267010
Dear
Ms. Krebs and Ms. Dao:
On
behalf of Rubicon Technologies, Inc. (the “Company”), please find below responses to the comments of the staff of the Securities
and Exchange Commission (the “Staff”) contained in the Staff’s letter dated December 28, 2022 (the “Comment Letter”)
with regard to the Registration Statement on Form S-1 (File No. 333-267010) filed by the Company on August 22, 2022 (the “Registration
Statement”) and amended on November 28, 2022 (the “Amended Registration Statement”). The responses are based on information
provided to us by the Company. Capitalized terms used but not defined herein have the respective meanings ascribed to them in the Amendment
No. 2 (as defined below).
Set
forth below in italics are the comments contained in the Staff’s Comment Letter pertaining to the Amended Registration Statement.
Immediately below each of the Staff’s comments is the Company’s response to that comment. For the convenience of the Staff’s
review, each of the numbered paragraphs below correspond to the numbered comment in the Comment Letter.
The
Company is concurrently providing to the Commission Amendment No. 2 to the Registration Statement, as filed on EDGAR on the date hereof
(“Amendment No. 2”).
Amendment
No. 1 to Form S-1
Certain
Financing Transactions
Forward
Purchase Agreements, page 118
1. Please
provide a plain English description of the risks and benefits to each of the company and
the FPA Sellers based upon how the OTC Equity Prepaid Forward Transaction operated. For example,
describe the best and worst potential outcomes for the company and for the FPA Sellers, highlighting
what factors would impact the outcomes. Explain why the company entered into the agreement
when the immediate outcome was the payment of $68.7 million to the FPA Sellers from the trust
account in addition to $246.0 to the remaining redeeming shareholders. Disclose the amount
remaining in the trust account after these payments.
Response:
The Company acknowledges the Staff’s comment and respectfully advises the Staff that it has revised its disclosure on pages
120 through 124 of Amendment No. 2 to include the requested disclosure.
January
3, 2023
Page 2
2. Please
disclose that the OTC Equity Prepaid Forward Transaction was terminated on 11/30/22. Disclose
what each FPA Seller received or retained under the termination agreements compared to what
each FPA Seller would have received if they had accelerated the maturity date, which right
had been triggered under the OTC Equity Prepaid Forward Transaction.
Response:
The Company acknowledges the Staff’s comment and respectfully advises the Staff that it has included additional disclosure
on pages v, vi, 124 and 125 of Amendment No. 2 to include the requested disclosure.
If
the Staff has any questions or comments regarding the foregoing, please contact the undersigned, Evan D’Amico of Gibson, Dunn &
Crutcher LLP, by telephone at (202) 887-3613 or via email at edamico@gibsondunn.com.
Sincerely,
/s/
Evan M. D’Amico
Evan
M. D’Amico